Li, X.; Chen, W.; Jia, Z.; Xiao, Y.; Shi, A.; Ma, X.
Mitochondrial Dysfunction as a Pathogenesis and Therapeutic Strategy for Metabolic-Dysfunction-Associated Steatotic Liver Disease. Int. J. Mol. Sci. 2025, 26, 4256.
https://doi.org/10.3390/ijms26094256
AMA Style
Li X, Chen W, Jia Z, Xiao Y, Shi A, Ma X.
Mitochondrial Dysfunction as a Pathogenesis and Therapeutic Strategy for Metabolic-Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences. 2025; 26(9):4256.
https://doi.org/10.3390/ijms26094256
Chicago/Turabian Style
Li, Xiangqiong, Wenling Chen, Zhuangzhuang Jia, Yahui Xiao, Anhua Shi, and Xuan Ma.
2025. "Mitochondrial Dysfunction as a Pathogenesis and Therapeutic Strategy for Metabolic-Dysfunction-Associated Steatotic Liver Disease" International Journal of Molecular Sciences 26, no. 9: 4256.
https://doi.org/10.3390/ijms26094256
APA Style
Li, X., Chen, W., Jia, Z., Xiao, Y., Shi, A., & Ma, X.
(2025). Mitochondrial Dysfunction as a Pathogenesis and Therapeutic Strategy for Metabolic-Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences, 26(9), 4256.
https://doi.org/10.3390/ijms26094256
